IGF1R and T-cell non-Hodgkin lymphoma: Our studies also showed that selective antagonism of IGF-IR with PPP decreased cell viability, induced apoptosis and G2/M-phase cell-cycle arrest, and decreased proliferation and colony formation of NPM-ALK+ T-cell lymphoma cells [22].